Voleon Capital Management’s Gilead Sciences GILD Stock Holding History

Voleon Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$715K	Buy	5,129 +2,941	+134%	+$412K	0.02%	504
2025 Q4	$269K	Sell	2,188 -14,836	-87%	-$1.8M	0.01%	682
2025 Q3	$1.89M	Sell	17,024 -4,962	-23%	-$564K	0.05%	321
2025 Q2	$2.44M	Sell	21,986 -348	-2%	-$37K	0.13%	155
2025 Q1	$2.5M	Sell	22,334 -34,020	-60%	-$3.51M	0.2%	119
2024 Q4	$5.21M	Buy	+56,354	New	+$5.07M	0.39%	74
2021 Q1	–	Sell	-75,000	Closed	-$4.37M	–	14
2020 Q4	$4.37M	Buy	+75,000	New	+$4.53M	0.47%	39
2019 Q1	–	Sell	-350,000	Closed	-$21.9M	–	37
2018 Q4	$21.9M	Buy	+350,000	New	+$24.5M	2.09%	19

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Voleon Capital Management's GILD Position: Q1 2026 in Review

Voleon Capital Management increased its Gilead Sciences (GILD) stake by 134% in Q1 2026, buying an estimated $412K and bringing the position to 5,129 shares worth $715K. The position accounts for 0.02% of the portfolio, ranked #504.

Voleon Capital Management first reported a position in GILD in Q4 2018 and has held it in 8 quarters since. The position peaked at $21.9M in Q4 2018. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Voleon Capital Management held 5,129 shares of Gilead Sciences worth $715K as of Q1 2026.
Voleon Capital Management bought 2,941 Gilead Sciences shares in Q1 2026, an estimated $412K.
Gilead Sciences made up 0.02% of Voleon Capital Management's portfolio in Q1 2026, its #504 holding.
Voleon Capital Management first reported a position in Gilead Sciences in Q4 2018 and has held it in 8 quarters since.
Voleon Capital Management's Gilead Sciences position peaked at $21.9M in Q4 2018.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Voleon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.